Go to Content

Physiologas Technologies Inc.
Research and development of cryptanalysis solutions using quantum computers

As of November, 2025

City Year of Establishment Founder
Sagamihara, Kanagawa 2020 Kazuyoshi MIYAWAKI
Kenichi KOKUBO
Partner VC Latest round of Fundraising Valuation
LOTTE HOLDINGS CO., LTD. Series A JPY 1,100 million

Program name

Deep-Tech Startups Support Program

Research theme

Research and development of cryptanalysis solutions using quantum computers

Business Plan

Home hemodialysis offers excellent patient quality of life and prognosis, but the barriers to implementation are high, and there are safety concerns, making it extremely unpopular. We are developing a system that is easy to implement as it does not require water supply and drainage piping, and is highly safe thanks to the use of various sensors. In this project, we will design and manufacture a prototype machine that is compatible with non-clinical and clinical trials, and prepare to obtain pharmaceutical approval in Japan, the United States, and Europe.

Research Outline

The project under grant aims to complete the production of a prototype so that the various tests (non-clinical and clinical trials) required for regulatory approval can be conducted in the next phase.

  1. Creation of various files
  2. Prototype production
  3. Functionality verification using the prototype
  4. Device testing in an in-house environment (including cybersecurity testing)
Phase Business Area/Field Research Period Research Grant Amount
STS Healthcare 2025-2027FY JPY 500 million

International collaborative technology demonstration

Countries/Regions Collaborative activity outline
United States, Australia
  • - Preparing for performance verification testing in Australia
  • - Conducting a pre-submission meeting with the U.S. Food and Drug Administration (FDA)

Last Updated : April 21, 2026